中国继续医学教育
中國繼續醫學教育
중국계속의학교육
China Continuing Medical Education
2015年
23期
92-94
,共3页
肋骨骨折%迟发性血胸%胸腔穿刺%胸腔闭式引流术%开胸治疗
肋骨骨摺%遲髮性血胸%胸腔穿刺%胸腔閉式引流術%開胸治療
륵골골절%지발성혈흉%흉강천자%흉강폐식인류술%개흉치료
Rib fracture%Delayed hemothorax%Pleural biopsy%Closed thoracic drainage%Thoracotomy
目的 探讨肋骨骨折合并迟发性血胸的治疗方法.方法 选取肋骨骨折合并迟发性血胸患者115例,根据治疗方案分为两组,对照组57例行开胸治疗,观察组58例行胸腔穿刺或胸腔闭式引流术治疗.结果 观察组手术时间、术后住院时间少于对照组,血性溶液抽出量多于对照组,呼吸困难病症改善时间、胸闷气短病症改善时间、胸腔积液病症改善时间、体温复常时间早于对照组,术后并发症发生率低于对照组,P<0.05,差异具有统计学意义.结论 胸腔穿刺或胸腔闭式引流术是肋骨骨折合并迟发性血胸的有效治疗方法.
目的 探討肋骨骨摺閤併遲髮性血胸的治療方法.方法 選取肋骨骨摺閤併遲髮性血胸患者115例,根據治療方案分為兩組,對照組57例行開胸治療,觀察組58例行胸腔穿刺或胸腔閉式引流術治療.結果 觀察組手術時間、術後住院時間少于對照組,血性溶液抽齣量多于對照組,呼吸睏難病癥改善時間、胸悶氣短病癥改善時間、胸腔積液病癥改善時間、體溫複常時間早于對照組,術後併髮癥髮生率低于對照組,P<0.05,差異具有統計學意義.結論 胸腔穿刺或胸腔閉式引流術是肋骨骨摺閤併遲髮性血胸的有效治療方法.
목적 탐토륵골골절합병지발성혈흉적치료방법.방법 선취륵골골절합병지발성혈흉환자115례,근거치료방안분위량조,대조조57례행개흉치료,관찰조58례행흉강천자혹흉강폐식인류술치료.결과 관찰조수술시간、술후주원시간소우대조조,혈성용액추출량다우대조조,호흡곤난병증개선시간、흉민기단병증개선시간、흉강적액병증개선시간、체온복상시간조우대조조,술후병발증발생솔저우대조조,P<0.05,차이구유통계학의의.결론 흉강천자혹흉강폐식인류술시륵골골절합병지발성혈흉적유효치료방법.
Objective To explore treatment methods of rib fractures and delayed hemothorax.Methods Selected 115 patients with rib fractures combined with delayed hemothorax, were divided into two groups by treatment methods. The control group had 57 patients were treated with thoracotomy. The observation group had 58 patients were treated thoracentesis or closed thoracic drainage.Results Operation time and postoperative hospitalization time in observation group were less than the control group, bloody solution extraction quantity in observation group was more than the control group, dyspnea symptom improvement time, chest tightness and breath shortness symptom improvement time, pleural effusion symptom improvement time, body temperature returned to normal time in observation group were earlier than control group. Incidence of postoperative complications in observation group was lower than control group,P<0.05, had difference statistically significance.Conclusion Thoracentesis or pleural closed drainage has an effective method in treatment of rib fracture and delayed hemothorax.